$5.92
At close: Mar 3, 6:16 PM EDT
$5.95
0.030.42%
After Hours: 6:16 PM EDT
Ocular Therapeutix reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ocular Therapeutix using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-03-03 | $-0.29 | $-0.22 | -31.8 % |
Q3 | 2024-11-14 | $-0.22 | $-0.21 | -4.76 % |
Q2 | 2024-08-07 | $-0.26 | $-0.22 | -18.2 % |
Q1 | 2024-05-07 | $-0.28 | $-0.19 | -47.4 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-03-03 | $17.08M | $16.89M | 1.14 % |
Q3 | 2024-11-14 | $15.43M | $17.14M | -10.0 % |
Q2 | 2024-08-07 | $16.44M | $15.82M | 3.93 % |
Q1 | 2024-05-07 | $14.77M | $15.41M | -4.13 % |
Ocular Therapeutix (OCUL) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on March 3, 2025 for Q4.
The Actual EPS was $-0.29, which missed the estimate of $-0.22.
The Actual Revenue was $17.1M, which beat the estimate of $16.9M.
Browse earnings estimates, EPS, and revenue on all stocks.